Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, CorMedix Inc maintains a gross margin of 89.26%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 49.24%, while the net margin is 104.11%. These profitability ratios, combined with a Return on Equity (ROE) of 75.08%, provide a clear picture of how effectively CRMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CRMD competes directly with industry leaders such as MGTX and PROK. With a market capitalization of $605.89M, it holds a leading position in the sector. When comparing efficiency, CRMD's gross margin of 89.26% stands against MGTX's 23.66% and PROK's 100.00%. Such benchmarking helps identify whether CorMedix Inc is trading at a premium or discount relative to its financial performance.
